JAZZ
$235.67+1.14%
as of close, Oct 2, 2026
☾ AH $235.67 +1.14%
Jazz Pharmaceuticals plc Common Stock (Ireland)Stock · Health CareNasdaq Composite 0.03%US Stock Market 0.02%Russell 3000 0.02%
JAZZ financial statements
The full income statement, balance sheet, and cash-flow statement for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 61.8M2024-09 60.5M2024-12 60.7M2025-03 61.6M2025-06 60.7M2025-09 60.8M2025-12 61.6M2026-03 62.7M2026-06 64.9M+5.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 4.27B+4.9% | 4.07B+6.1% | 3.83B+4.8% | 3.66B+18.3% | 3.09B+30.9% | |
| Research & development | 783M-11.5% | 884M+4.0% | 850M+43.9% | 590M+16.7% | 506M+50.8% | |
| Selling, general & administrative | 1.81B+30.6% | 1.39B+3.1% | 1.34B-5.2% | 1.42B-2.4% | 1.45B+69.9% | |
| Amortization of intangibles | 655M+4.4% | 627M+3.1% | 608M+1.5% | 599M+14.0% | 526M+102.5% | |
| Operating income | -430M-160.0% | 717M+23.9% | 579M+983.0% | -65.5M-138.5% | 170M-55.0% | |
| Interest expense | — | — | 32.8M+0.0% | 32.8M-63.5% | 89.9M+2.6% | |
| Interest & investment income | 85.8M-19.3% | 106M+63.3% | 65.1M+466.1% | 11.5M+538.9% | 1.80M-83.8% | |
| Equity-method income | -732K+55.9% | -1.66M+44.8% | -3.01M+69.7% | -9.92M-1289.5% | -714K+75.9% | |
| Pre-tax income | -628M-233.5% | 470M+57.9% | 298M+179.9% | -373M-230.4% | -113M-141.0% | |
| Income tax | -272M-198.0% | -91.4M+23.8% | -120M+24.4% | -159M-173.4% | 216M+544.8% | |
| Net income | -356M-163.6% | 560M+35.0% | 415M+285.1% | -224M+32.0% | -330M-238.2% | |
| -$5.84-167.5% | $8.65+41.8% | $6.10+270.4% | -$3.58+35.1% | -$5.52-230.8% | ||
| EPS (basic) | -$5.84-164.5% | $9.06+38.3% | $6.55+283.0% | -$3.58+35.1% | -$5.52-229.0% | |
| Weighted-avg shares (basic) | 61.0M-1.4% | 61.8M-2.3% | 63.3M+1.2% | 62.5M+4.8% | 59.7M+7.1% | |
| Weighted-avg shares (diluted) | 61.0M-7.6% | 66.0M-8.4% | 72.1M+15.2% | 62.5M+4.8% | 59.7M+5.6% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 4.17B-10.0% | 4.63B+34.7% | 3.44B+31.8% | 2.61B-0.2% | 2.61B-8.0% | ||
| Cash & equivalents | 1.39B-42.3% | 2.41B+60.2% | 1.51B+70.9% | 881M+49.0% | 591M-44.1% | |
| Cash & short-term investments | 2.44B | — | — | — | — | |
| Accounts receivable | 831M+15.9% | 717M+1.6% | 706M+8.3% | 651M+15.6% | 563M+42.1% | |
| Inventory | 417M-13.2% | 480M-19.5% | 597M-16.4% | 714M-33.4% | 1.07B+1024.5% | |
| Prepaid expenses | 153M-14.0% | 177M-4.3% | 185M+101.8% | 91.9M-30.1% | 131M+110.5% | |
| Other current assets | 324M+23.8% | 262M-18.5% | 321M+20.1% | 267M+5.9% | 252M+65.5% | |
| 11.7B-2.9% | 12.0B+5.4% | 11.4B+5.2% | 10.8B-11.9% | 12.3B+88.2% | ||
| Operating lease right-of-use | 58.9M+9.9% | 53.6M-18.0% | 65.3M-10.9% | 73.3M-15.3% | 86.6M-33.0% | |
| Goodwill | 1.83B+6.6% | 1.72B-2.1% | 1.75B+3.6% | 1.69B-7.4% | 1.83B+90.7% | |
| Intangible assets | 4.43B-6.9% | 4.76B-12.2% | 5.42B-6.5% | 5.79B-19.0% | 7.15B+225.8% | |
| Deferred tax assets | 869M+55.1% | 560M+17.2% | 478M+27.0% | 376M+20.9% | 311M+22.0% | |
| Other non-current assets | 99.0M-13.5% | 114M+69.7% | 67.5M+22.4% | 55.1M+35.1% | 40.8M+58.7% | |
| 2.24B+115.9% | 1.04B-32.4% | 1.54B+64.7% | 933M+15.3% | 809M+23.8% | ||
| Accounts payable | 122M+56.8% | 77.9M-24.2% | 103M+13.2% | 90.8M-9.5% | 100M+272.2% | |
| Accrued liabilities | 1.03B+13.5% | 911M+14.7% | 794M-1.2% | 803M+20.6% | 666M+88.9% | |
| Deferred revenue | — | — | 0.00-100.0% | 463K-77.9% | 2.09M-17.8% | |
| Short-term & current debt | 1.03B+3222.3% | 31.0M-94.9% | 605M+1851.5% | 31.0M+0.0% | 31.0M-87.4% | |
| Current lease liability | 14.3M-0.4% | 14.3M-24.6% | 19.0M+22.3% | 15.6M+1.3% | 15.4M+6.2% | |
| Finance lease liability (current) | 439K-2.0% | 448K+4.7% | 428K+12.3% | 381K-6.2% | 406K | |
| Long-term debt | 4.33B-28.8% | 6.08B+19.0% | 5.11B-10.3% | 5.69B-5.4% | 6.02B+225.6% | |
| Deferred revenue (non-current) | — | — | — | 0.00-100.0% | 463K-80.0% | |
| Non-current lease liability | 50.9M+30.7% | 38.9M-34.3% | 59.2M-17.6% | 71.8M-17.6% | 87.2M-37.7% | |
| Operating lease liability (total) | 65.2M+22.3% | 53.3M-31.9% | 78.2M-10.5% | 87.4M-14.8% | 103M-33.6% | |
| Finance lease liability (total) | 3.88M-22.6% | 5.01M-8.4% | 5.47M-2.2% | 5.59M-16.2% | 6.67M | |
| Finance lease liability | 3.44M-24.6% | 4.56M-9.5% | 5.04M-3.3% | 5.21M-16.9% | 6.27M | |
| Deferred tax liabilities | 595M-12.2% | 677M-20.2% | 848M-10.2% | 944M-27.4% | 1.30B+897.4% | |
| Other non-current liabilities | 124M+43.6% | 86.6M-17.3% | 105M-1.9% | 107M-8.7% | 117M+15.7% | |
| 4.32B+5.5% | 4.09B+9.5% | 3.74B+21.1% | 3.09B-22.2% | 3.97B+8.3% | ||
| Common stock | 0.00-100.0% | 6.00K+0.0% | 6.00K+0.0% | 6.00K+0.0% | 6.00K+0.0% | |
| Additional paid-in capital | 4.24B+8.4% | 3.91B+5.8% | 3.70B+6.4% | 3.48B-1.6% | 3.53B+34.2% | |
| Retained earnings | 646M-42.7% | 1.13B+28.3% | 879M+19.8% | 734M-11.6% | 830M-28.4% | |
| Accumulated other comprehensive income | -569M+40.0% | -948M-12.5% | -842M+25.2% | -1.13B-181.1% | -400M-198.0% | |
| Total liabilities & equity | 11.7B-2.9% | 12.0B+5.4% | 11.4B+5.2% | 10.8B-11.9% | 12.3B+88.2% | |
| Common shares issued | 61.4M+1.3% | 60.6M-2.6% | 62.3M-1.5% | 63.2M+2.6% | 61.6M+9.7% | |
| Common shares outstanding | 61.4M+1.3% | 60.6M-2.6% | 62.3M-1.5% | 63.2M+2.6% | 61.6M+9.7% | |
| Shares outstanding (cover) | 61.6M+1.4% | 60.7M-2.6% | 62.3M-1.6% | 63.3M+2.6% | 61.7M+9.6% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.36B-2.9% | 1.40B+27.8% | 1.09B-14.1% | 1.27B+63.4% | 779M-13.5% | ||
| Depreciation & amortization | 41.6M+26.8% | 32.8M+7.9% | 30.4M+0.3% | 30.3M+13.5% | 26.7M+42.8% | |
| Intangible amortization | 655M+4.4% | 627M+3.1% | 608M+1.5% | 599M+14.0% | 526M+102.5% | |
| Share-based compensation | 291M+17.4% | 248M+9.3% | 227M+2.2% | 222M+17.5% | 189M+56.2% | |
| Deferred income taxes | -445M-113.6% | -208M+19.9% | -260M+11.0% | -292M-522.3% | 69.2M+150.5% | |
| Change in receivables | 106M+403.3% | 21.1M-59.3% | 51.9M-42.4% | 90.1M-2.8% | 92.7M+140.0% | |
| Change in inventory | 86.0M+88.9% | 45.5M+239.4% | 13.4M-73.0% | 49.6M+1.6% | 48.9M+60.0% | |
| Change in payables | 39.9M+298.5% | -20.1M-309.0% | 9.60M+185.6% | -11.2M-119.7% | 57.0M+401.1% | |
| -1.51B-197.1% | -508M-211.7% | -163M+63.5% | -446M+91.4% | -5.21B-417.2% | ||
| Capital expenditure | 58.8M+54.3% | 38.1M+58.9% | 24.0M-17.5% | 29.0M+5.1% | 27.6M+84.2% | |
| Free cash flow | 1.30B-4.5% | 1.36B+27.1% | 1.07B-14.1% | 1.24B+65.5% | 751M-15.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 6.23B | |
| Purchases of investments | 1.83B+40.2% | 1.31B+234.6% | 390M+539.1% | 61.0M+127.6% | 26.8M-98.9% | |
| Sales/maturities of investments | 1.36B+60.9% | 845M+213.0% | 270M+350.0% | 60.0M-94.5% | 1.09B-37.6% | |
| -873M-4357.1% | 20.5M+106.7% | -305M+42.3% | -529M-113.3% | 3.97B+651.9% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.47B | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 125M-59.9% | 311M+15.4% | 270M+499457.4% | 54.0K | 0.00-100.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 6.55M+491.3% | -1.68M-247.3% | 1.14M+118.3% | -6.22M-94.0% | -3.21M-957.5% | |
| Net change in cash | -1.02B-212.6% | 907M+45.1% | 625M+115.4% | 290M+162.2% | -466M-210.9% | |
| Interest paid | 249M-21.0% | 315M-5.5% | 333M+23.1% | 271M+95.8% | 138M+225.6% | |
| Income taxes paid | 122M+6.0% | 115M-35.4% | 178M+87.9% | 94.7M-65.1% | 271M+19.6% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 10.5B+39.9% | 7.48B-3.4% | 7.74B-22.8% | 10.0B+27.5% | 7.87B-15.4% | |
| P/E | — | 13.4×-86.2% | 96.9× | — | — | |
| P/S | 2.5×+33.4% | 1.8×-9.9% | 2.0×-27.1% | 2.8×+10.1% | 2.5×-35.4% | |
| P/B | 2.4×+32.6% | 1.8×-17.7% | 2.2×-39.3% | 3.7×+84.2% | 2.0×-21.9% | |
| P/FCF | 8.1×+46.5% | 5.5×-11.6% | 6.2×-33.1% | 9.3×-11.2% | 10.5×-0.3% | |
| Earnings yield | — | 7.5%+625.3% | 1.0% | — | — | |
| FCF yield | 12.4%-31.7% | 18.2%+13.1% | 16.1%+49.4% | 10.7%+12.6% | 9.5%+0.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: JAZZ’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all JAZZ filings on SEC EDGAR → Not investment advice.